Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients C Guignant, A Lepape, X Huang, H Kherouf, L Denis, F Poitevin, ... Critical care 15 (2), R99, 2011 | 335 | 2011 |
Early assessment of leukocyte alterations at diagnosis of septic shock F Venet, F Davin, C Guignant, A Larue, MA Cazalis, R Darbon, ... Shock 34 (4), 358-363, 2010 | 210 | 2010 |
Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma A Cheron, B Floccard, B Allaouchiche, C Guignant, F Poitevin, C Malcus, ... Critical Care 14 (6), R208, 2010 | 184 | 2010 |
Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma A Gouel-Chéron, B Allaouchiche, C Guignant, F Davin, B Floccard, ... PloS one 7 (3), e33095, 2012 | 162 | 2012 |
Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients C Guignant, N Voirin, F Venet, F Poitevin, C Malcus, J Bohé, A Lepape, ... Intensive care medicine 35 (11), 1859, 2009 | 130 | 2009 |
Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients L Zabijak, C Attencourt, C Guignant, D Chatelain, P Marcelo, ... Cancer immunology, immunotherapy 64 (12), 1601-1608, 2015 | 113 | 2015 |
Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients F Venet, R Gebeile, J Bancel, C Guignant, F Poitevin-Later, C Malcus, ... International immunopharmacology 11 (12), 2086-2090, 2011 | 96 | 2011 |
Th17 and CD24 hi CD27+ regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis S Salomon, C Guignant, P Morel, G Flahaut, C Brault, C Gourguechon, ... Arthritis research & therapy 19 (1), 33, 2017 | 50 | 2017 |
Paradoxical articular manifestations in patients with inflammatory bowel diseases treated with infliximab H Thiebault, P Boyard-Lasselin, C Guignant, N Guillaume, A Wacrenier, ... European journal of gastroenterology & hepatology 28 (8), 876-881, 2016 | 41 | 2016 |
Increased MerTK expression in circulating innate immune cells of patients with septic shock C Guignant, F Venet, S Planel, J Demaret, A Gouel-Chéron, C Nougier, ... Intensive care medicine 39 (9), 1556-1564, 2013 | 34 | 2013 |
Upregulation of the pro-apoptotic genes BID and FAS in septic shock patients F Turrel-Davin, C Guignant, A Lepape, B Mougin, G Monneret, F Venet Critical Care 14 (4), R133, 2010 | 31 | 2010 |
Persistent high level of circulating midregional-proadrenomedullin and increased risk of nosocomial infections after septic shock C Guignant, N Voirin, F Venet, A Lepape, G Monneret Journal of Trauma and Acute Care Surgery 72 (1), 293-296, 2012 | 17 | 2012 |
Innovative therapeutic strategies for restoring lymphocyte functions in septic patients F Turrel, C Guignant, F Venet, A Lepape, G Monneret Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets …, 2008 | 17 | 2008 |
Flow cytometry developments and perspectives in clinical studies: examples in ICU patients F Venet, C Guignant, G Monneret Cell Cycle Synchronization, 261-275, 2011 | 15 | 2011 |
Proatrial natriuretic peptide is a better predictor of 28-day mortality in septic shock patients than proendothelin-1 C Guignant, F Venet, N Voirin, F Poitevin, C Malcus, J Bohé, A Lepape, ... Clinical chemistry and laboratory medicine 48 (12), 1813-1820, 2010 | 12 | 2010 |
Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells H Ghamlouch, W Darwiche, A Hodroge, H Ouled-Haddou, S Dupont, ... Oncotarget 6 (21), 18484, 2015 | 10 | 2015 |
Assessment of cellular immune parameters in paediatric toxic shock syndrome: a report of five cases O Dauwalder, F Venet, E Javouhey, C Badiou, Y Gillet, C Guignant, ... FEMS Immunology & Medical Microbiology 66 (1), 116-119, 2012 | 5 | 2012 |
The Baseline Th17 Lymphocytes Level Is a Predictive Marker of Good Response to Biologics in Rheumatoid Arthritis S Salomon, C Guignant, P Morel, B Gubler, P Fardellone, JP Marolleau, ... ARTHRITIS & RHEUMATOLOGY 68, 2016 | | 2016 |
AB0025 Evolution of Regulatory B Cells under Treatment by Biologics in Rheumatoid Arthritis S Salomon, C Guignant, C Brault, G Flahaut, B Gubler, P Fardellone, ... Annals of the Rheumatic Diseases 75, 905, 2016 | | 2016 |
Lymphocytose polyclonale à lymphocytes binucléés: une cause de déficit immunitaire humoral? C Guignant, A Mambie, M Diouf, C Roumier, C Roche-Lestienne, ... La Revue de Médecine Interne 37, A49-A50, 2016 | | 2016 |